reports
- Carole Braudeau
Credit Morning 09/17/2025
Fnac Darty is reportedly interested in acquiring Engie Home Services|Schaeffler CMD: Company details 2028 mid-term targets; some de-leveraging is part of this|ZF materially upsizes USD bond issuance|Altice France: Patrick Drahi is preparing to relaunch the sale of Xpfibre (FT)|
- Carole Braudeau
Morning Crédit 17/09/2025
Fnac Darty serait candidat au rachat d’Engie Home Services|Schaeffler CMD: Company details 2028 mid-term targets; some de-leveraging is part of this|ZF materially upsizes USD bond issuance|Altice France : Patrick Drahi s’apprêterait à relancer la vente de Xpfibre (Financial Times)|
- Carole Braudeau
Morning Crédit 16/09/2025
VF Corp. annonce la cession de la marque Dickies pour 600 m USD en numéraire|ZF addresses debt maturities via two Eurobond tender offers; aims USD 750m issuance|Bertrand Franchise : baisse des résultats au T2 25 dans un contexte de consommation morose en France|Paprec a publié un EBITDA en hausse de +31% au S1 25.|
- Geoffroy Michalet
- Carole Braudeau
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
DGE DIAGEO PLC
SU SCHNEIDER ELECTRIC SE
OSE OSE IMMUNOTHERAPEUTICS SA
RI PERNOD RICARD SA
HO THALES SA
RCO REMY COINTREAU SA
EVT EVOTEC SE
MF WENDEL SE
A1XEH4 CROSSJECT SA
TNG TRANSGENE SA
ABVX ABIVAX SA
IPH INNATE PHARMA SA CLASS A
VLS VALNEVA SE
ISP INTESA SANPAOLO S.P.A.
GNFT GENFIT SA
UCG UNICREDIT S.P.A.
SIGHT GENSIGHT BIOLOGICS SA
ADOC ADOCIA SA
FYB FORMYCON AG
GLPG GALAPAGOS NV
ALVAL VALBIOTIS SA
MOL MOL HUNGARIAN OIL & GAS PLC CLASS A
MEDCL MEDINCELL SA
CPR DAVIDE CAMPARI-MILANO N.V.
AELIS AELIS FARMA SA
BAI BENEVOLENTAI
OSE OSE IMMUNOTHERAPEUTICS SA
EVT EVOTEC SE
MF WENDEL SE
A1XEH4 CROSSJECT SA
TNG TRANSGENE SA
ABVX ABIVAX SA
ALDEL DELFINGEN INDUSTRY SA
IPH INNATE PHARMA SA CLASS A
VIRP VIRBAC SA
VLS VALNEVA SE
GBT GUERBET SA
GOE GROUPE GORGE SA
ISP INTESA SANPAOLO S.P.A.
TIETO TIETOEVRY OYJ
GNFT GENFIT SA
SESL SES-IMAGOTAG SA
UCG UNICREDIT S.P.A.
SIGHT GENSIGHT BIOLOGICS SA
ADOC ADOCIA SA
FYB FORMYCON AG
FLU FLUGHAFEN WIEN AG
GLPG GALAPAGOS NV
ALVAL VALBIOTIS SA
MEDCL MEDINCELL SA
UPG UNIFIEDPOST GROUP
ECMPA EUROCOMMERCIAL PROPERTIES NV
AELIS AELIS FARMA SA
BAI BENEVOLENTAI
OSE OSE IMMUNOTHERAPEUTICS SA
EVT EVOTEC SE
MF WENDEL SE
A1XEH4 CROSSJECT SA
TNG TRANSGENE SA
ABVX ABIVAX SA
ALDEL DELFINGEN INDUSTRY SA
IPH INNATE PHARMA SA CLASS A
VIRP VIRBAC SA
VLS VALNEVA SE
GBT GUERBET SA
GOE GROUPE GORGE SA
ISP INTESA SANPAOLO S.P.A.
TIETO TIETOEVRY OYJ
GNFT GENFIT SA
SESL SES-IMAGOTAG SA
UCG UNICREDIT S.P.A.
SIGHT GENSIGHT BIOLOGICS SA
ADOC ADOCIA SA
FYB FORMYCON AG
FLU FLUGHAFEN WIEN AG
GLPG GALAPAGOS NV
ALVAL VALBIOTIS SA
MEDCL MEDINCELL SA
UPG UNIFIEDPOST GROUP
ECMPA EUROCOMMERCIAL PROPERTIES NV
AELIS AELIS FARMA SA
BAI BENEVOLENTAI
BVI BUREAU VERITAS SA
ADP AEROPORTS DE PARIS SA
DGE DIAGEO PLC
SU SCHNEIDER ELECTRIC SE
OSE OSE IMMUNOTHERAPEUTICS SA
RI PERNOD RICARD SA
HO THALES SA
RCO REMY COINTREAU SA
EVT EVOTEC SE
MF WENDEL SE
A1XEH4 CROSSJECT SA
TNG TRANSGENE SA
ABVX ABIVAX SA
IPH INNATE PHARMA SA CLASS A
VLS VALNEVA SE
ISP INTESA SANPAOLO S.P.A.
GNFT GENFIT SA
UCG UNICREDIT S.P.A.
SIGHT GENSIGHT BIOLOGICS SA
ADOC ADOCIA SA
FYB FORMYCON AG
GLPG GALAPAGOS NV
ALVAL VALBIOTIS SA
MOL MOL HUNGARIAN OIL & GAS PLC CLASS A
MEDCL MEDINCELL SA
CPR DAVIDE CAMPARI-MILANO N.V.
AELIS AELIS FARMA SA
BAI BENEVOLENTAI
- Geoffroy Michalet
WENDEL: Management of the Exchangeable Bond maturing in 2026: successf...
WENDEL: Management of the Exchangeable Bond maturing in 2026: successful completion of the accelerated placement of approximately 23 million Bureau Veritas shares Management of the Exchangeable Bond maturing in 2026: successful completion of the accelerated placement of approximately 23 million Bureau Veritas shares Paris, 16 September 2025 - Wendel announces the successful completion of the disposal of the 23.3 million Bureau Veritas shares underlying the exchangeable bond into Bureau Veritas shares issued by Wendel in March 2023 and maturing in March 2026 (the "EB"), for a total a...
WENDEL : Opération de gestion de l’Obligation Echangeable de maturité ...
WENDEL : Opération de gestion de l’Obligation Echangeable de maturité 2026: succès du placement accéléré d’environ 23 millions d’actions Bureau Veritas Opération de gestion de l’Obligation Echangeable de maturité 2026: succès du placement accéléré d’environ 23 millions d’actions Bureau Veritas Paris, le 16 septembre 2025 – Wendel annonce le succès de la cession des 23,3 millions actions Bureau Veritas, sous-jacentes à l’obligation échangeable en titres Bureau Veritas émise par Wendel en mars 2023 et arrivant à échéance en mars 2026 (l’"OE") pour un montant total d'environ 591 millions d'...
Wendel: Management of the Exchangeable Bond maturing in 2026: accelera...
Wendel: Management of the Exchangeable Bond maturing in 2026: accelerated placement of approximately 23 million Bureau Veritas shares Management of the Exchangeable Bond maturing in 2026: accelerated placement of approximately 23 million Bureau Veritas shares Paris, 15 September 2025 - Wendel announces the launch of the disposal of the 23.3 million Bureau Veritas shares underlying the exchangeable bond into Bureau Veritas shares issued by Wendel in March 2023 and maturing in March 2026 (the "EB"), through an accelerated bookbuilding process reserved for qualified investors as defined by Ar...
WENDEL : Opération de gestion de l’Obligation Echangeable de maturité ...
WENDEL : Opération de gestion de l’Obligation Echangeable de maturité 2026 : placement accéléré d’environ 23 millions d’actions Bureau Veritas Opération de gestion de l’Obligation Echangeable de maturité 2026 : placement accéléré d’environ 23 millions d’actions Bureau Veritas Paris, le 15 septembre 2025 - Wendel annonce le lancement de la cession des 23,3 millions d’actions Bureau Veritas sous-jacentes à l’obligation échangeable en titres Bureau Veritas émise par Wendel en mars 2023 et arrivant à échéance en mars 2026 (l’"OE") dans le cadre d’un placement par voie de construction accélérée...
WENDEL : Déclaration des opérations de rachat d'actions réalisées au 1...
WENDEL : Déclaration des opérations de rachat d'actions réalisées au 12 septembre 2025 Déclaration des opérations de rachat d’actions réalisées dans les conditions de l’article 5.2 du règlement (UE) n°596/2014 du 16 avril 2014 sur les abus de marché Programme de rachat d’actions autorisé par l’Assemblée Générale du 15 mai 2025 Conformément à la réglementation applicable, Wendel déclare avoir réalisé les opérations de rachat d’actions suivantes dans les conditions de l’article 5.2 du règlement (UE) n°596/2014, entre les 8 et 12 septembre 2025 : Nom de l'émetteurCode LEIJour de la transact...
- Carole Braudeau
- Carole Braudeau
Brenntag SE: 1 director
A director at Brenntag SE bought 6,000 shares at 50.863EUR and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- Lynn Hautekeete
Basic-Fit Frontloaded Costs, Strengthened Liquidity, and Upward Valuat...
We revise our FY25 and FY26 underlying EBITDA less rent forecasts upward by +3.2% and +1.7%, respectively. Our FY25 estimate now stands at EUR 343.6m, which remains at the lower end of management's guidance range (EUR 330–370m). Importantly, we lower our risk premium following the EUR 350.0m in additional secured bank financing obtained in 1H25. This enhanced liquidity profile and extended maturities reduce refinancing risk and support our confidence in Basic-Fit's capital structure. As a result...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.